X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8539) 8539
Conference Proceeding (135) 135
Book Chapter (95) 95
Book / eBook (62) 62
Dissertation (23) 23
Patent (16) 16
Magazine Article (8) 8
Publication (8) 8
Journal / eJournal (4) 4
Paper (2) 2
Standard (2) 2
Book Review (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4658) 4658
end-points (2728) 2728
male (2123) 2123
female (1932) 1932
middle aged (1364) 1364
treatment outcome (1299) 1299
aged (1246) 1246
oncology (1096) 1096
cardiac & cardiovascular systems (1046) 1046
clinical-trials (950) 950
clinical trials (923) 923
end-point (889) 889
adult (875) 875
end-point reduction (871) 871
animals (857) 857
mortality (766) 766
analysis (750) 750
pharmacology & pharmacy (736) 736
risk factors (717) 717
surrogate end-points (710) 710
losartan intervention (662) 662
cancer (634) 634
hypertension (621) 621
biomarkers (577) 577
research (564) 564
aged, 80 and over (525) 525
prognosis (523) 523
care and treatment (521) 521
peripheral vascular disease (520) 520
time factors (502) 502
survival (501) 501
statistics & probability (485) 485
abridged index medicus (468) 468
toxicology (468) 468
hypertension - drug therapy (451) 451
risk (431) 431
therapy (424) 424
outcomes (410) 410
clinical trials as topic (390) 390
chemotherapy (388) 388
medicine, general & internal (383) 383
antihypertensive agents - therapeutic use (376) 376
randomized controlled trials as topic (371) 371
disease progression (361) 361
surgery (360) 360
medicine, research & experimental (352) 352
end-point definitions (346) 346
patients (343) 343
prospective studies (343) 343
environmental sciences (341) 341
risk assessment (341) 341
research design (336) 336
follow-up studies (319) 319
medical research (316) 316
double-blind (310) 310
quality of life (307) 307
drug therapy (306) 306
health aspects (306) 306
randomized-trial (301) 301
blood-pressure (298) 298
medicine & public health (296) 296
diagnosis (293) 293
studies (291) 291
reproducibility of results (289) 289
retrospective studies (289) 289
validation (289) 289
urology & nephrology (283) 283
survival analysis (282) 282
trials (279) 279
toxicity (275) 275
cardiovascular morbidity (273) 273
public, environmental & occupational health (272) 272
disease-free survival (270) 270
severity of illness index (268) 268
disease (261) 261
usage (259) 259
quality-of-life (258) 258
antineoplastic agents - therapeutic use (255) 255
mathematical & computational biology (249) 249
efficacy (243) 243
hypertension - complications (243) 243
left-ventricular hypertrophy (242) 242
prevention (240) 240
patient outcomes (238) 238
adolescent (234) 234
predictive value of tests (234) 234
cardiovascular (231) 231
gastroenterology & hepatology (227) 227
progression-free survival (226) 226
medicine (225) 225
young adult (224) 224
neurosciences (223) 223
stroke (223) 223
trial (219) 219
methods (217) 217
proportional hazards models (213) 213
management (212) 212
medicine, experimental (211) 211
blood pressure (210) 210
heart failure (208) 208
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (42) 42
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
UofT at Mississauga - Stacks (7) 7
UofT at Scarborough - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Circulation Desk (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8671) 8671
Japanese (130) 130
French (76) 76
German (76) 76
Spanish (37) 37
Russian (29) 29
Portuguese (21) 21
Chinese (14) 14
Polish (10) 10
Korean (8) 8
Czech (4) 4
Dutch (4) 4
Norwegian (4) 4
Italian (3) 3
Hungarian (2) 2
Chamorro (1) 1
Esperanto (1) 1
Persian (1) 1
Slovenian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Genetic testing and molecular biomarkers, ISSN 1945-0265, 2009
Journal
Molecular diagnosis & therapy, ISSN 1177-1062, 2006
Journal
American journal of kidney diseases, ISSN 0272-6386, 2017, Volume 70, Issue 4, pp. 464 - 475
Journal Article
2006, 2nd ed., ISBN 9780120885626, xix, 919 p., [6] p. of plates
This updated edition is a comprehensive treatise that spans the complete range of basic biochemistry of bone and cartilage components to the clinical... 
Cartilage | Bones | Extracellular matrix | Metabolism | Disorders | Biochemical markers
Book
Annals of oncology, ISSN 0923-7534, 2019, Volume 30, Issue 5, pp. 830 - 838
Abstract Background Pragmatic end points, such as time-to-treatment discontinuation (TTD), defined as the date of starting a medication to the date of... 
1ST-LINE ERLOTINIB | end points | MULTICENTER | OPEN-LABEL | DOCETAXEL | real world | CISPLATIN | ONCOLOGY | RESPONSE EVALUATION CRITERIA | CRIZOTINIB | time to discontinuation | END-POINTS | NIVOLUMAB | PROGRESSION
Journal Article
Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons... 
Biochemical markers
eJournal
American journal of kidney diseases, ISSN 0272-6386, 2014, Volume 64, Issue 5, pp. 714 - 722
Background Increased systolic blood pressure variability between outpatient visits is associated with increased incidence of cardiovascular end points.... 
Nephrology | diabetic kidney disease | kidney disease outcomes | Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) | Visit-to-visit variability in blood pressure | systolic blood pressure (SBP) | MORTALITY | Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) | ATHEROSCLEROSIS | RISK | MELLITUS | IMPACT | DISEASE | AFRICAN-AMERICANS | HYPERTENSION | ASSOCIATION | PROGRESSION | Reduction of End Points in NonInsulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) | UROLOGY & NEPHROLOGY | Kidney - physiology | Prospective Studies | Tetrazoles - pharmacology | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Diabetic Nephropathies - diagnosis | Angiotensin II Type 1 Receptor Blockers - pharmacology | Biphenyl Compounds - therapeutic use | Diabetic Nephropathies - physiopathology | Biphenyl Compounds - pharmacology | Female | Blood Pressure - drug effects | Blood Pressure - physiology | Cardiovascular Diseases - diagnosis | Cardiovascular Diseases - physiopathology | Kidney - drug effects | Double-Blind Method | Treatment Outcome | Office Visits - trends | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - physiopathology | Tetrazoles - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Cohort Studies
Journal Article
Journal Article
2007, 1. Aufl., Wiley-Interscience series on mass spectrometry, ISBN 9780471745167, xxiv, 377
Tools, techniques, and progress in cancer biomarkers discovery The completion of a number of gene sequencing projects, recent advances in genomic and proteomic... 
Science | Spectroscopy & Spectrum Analysis | Tumor markers
Book
The European respiratory journal, ISSN 0903-1936, 01/2019, Volume 53, Issue 1
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability over the past 15 years of multiple drugs interfering with... 
5 INHIBITOR THERAPY | SURROGATE END-POINTS | RESPIRATORY SYSTEM | COMBINATION THERAPY | PROSTACYCLIN ANALOG | EISENMENGER-SYNDROME | ENDOTHELIN-RECEPTOR ANTAGONIST | DOUBLE-BLIND | CONTINUOUS INTRAVENOUS EPOPROSTENOL | ORAL TREPROSTINIL | HEMODYNAMIC PARAMETERS
Journal Article
2011, ISBN 9781439819791, xi, 285
Book
Current opinion in HIV & AIDS, ISSN 1746-630X, 2010, Volume 5, Issue 6, pp. 463 - 466
PURPOSE OF REVIEWThis article provides working definitions and a conceptual framework to understand the roles of biomarkers in clinical research. RECENT... 
Biomarkers | clinical endpoints | surrogate endpoints | INFECTIOUS DISEASES | SURROGATE END-POINTS | biomarkers | CLINICAL-TRIALS | ENDPOINTS | IMMUNOLOGY | Biomedical Research | Reproducibility of Results | Diagnosis | Humans
Journal Article
Addiction (Abingdon, England), ISSN 0965-2140, 2012, Volume 107, Issue 4, pp. 694 - 708
Journal Article
2011
Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons... 
Biochemical markers
eJournal
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 10, pp. 919 - 931
Journal Article